uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Isturisa
Authorised
Human
Orphan medicine
Details
EMA number
EMEA/H/C/004821
ATC code
H02CA02
Authorisation
9 January 2020
Revision
7
EMA page
Therapeutic indication
Isturisa is indicated for the treatment of endogenous Cushing’s syndrome in adults.
MeSH:
Cushing Syndrome
Group:
Corticosteroids for systemic use
Active substances
osilodrostat phosphate
Marketing Authorisation Holder
Recordati Rare Diseases
MAH
Timeline
Filter by authority:
EMA
Isturisa authorised
9 Jan 2020
authorised
regulatory
Isturisa | uMedical